Upload
caldwell-mcclain
View
19
Download
1
Embed Size (px)
DESCRIPTION
RG2. Ad-Flt3L/TK. Rapamycin (150 µg/kg/day). 40. GCV. d 0. 5. 12. Supplementary figure 5: Low dose Rapamycin does not enhance Ad-Flt3L + Ad-TK/GCV immunotherapy. a. b. - PowerPoint PPT Presentation
Citation preview
RG2
d 0 5 12
40
Ad-Flt3L/TK
Rapamycin (150µg/kg/day)
GCV
a
b
Supplementary figure 5:Low dose Rapamycin does not enhance Ad-Flt3L + Ad-TK/GCV immunotherapy